Neurovations
Napa, California, 94558, United States
Location status: Recruiting
NCT Number: NCT07122453
This clinical study is being conducted to evaluate the safety, tolerability, plasma pharmacokinetics and efficacy of an investigational drug called CNTX-3001. This Phase 1 study is the first time that CNTX-3001 will be given to people (first-in-human study). The study is being done to evaluate whether CNTX-3001, given into the intrathecal space by lumbar puncture, can be administered safely to participants who have been diagnosed with intractable chronic moderate to severe low back pain and who have not responded well to other treatments in the past.
CNTX-3001 is a novel, non-opioid small molecule
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Phase 1
Napa, California, 94558, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion:
Exclusion
Exclusion
non-opioid analgesic
Placebo product
Time frame: From baseline to the end of treatment visit (Day 7)
Number of participants with TEAEs, which includes laboratory test variables
Time frame: Pre dose to up to 4 hours post dose
Time frame: Pre dose to up to 4 hours post dose
Time frame: Pre dose to up to 4 hours post dose
Contact information is provided by the study sponsor or research team.
Centrexion Therapeutics
Industry
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Single Ascending Doses of Intrathecal CNTX-3001 in Subjects With Intractable Chronic Moderate to Severe Low Back Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07587047
Back Pain, Chronic Lower Back Pain
Winter Park, Florida, United States
View Trial DetailsNCT07615816
Back Pain, Low Back Pain
Joint Base Lewis McChord, Washington, United States
View Trial DetailsNCT04982965
Back Pain, Bone Diseases
La Jolla, California, United States
View Trial DetailsNCT07040397
Back Pain, Low Back Pain
Rochester, Minnesota, United States
View Trial Details